Intercept Pharmaceuticals (ICPT)
104.78
+0.69 +0.66%
NASDAQ
Aug 16, 11:22
Delayed 2m
USD
View All Key Stats
ICPT Key Stats
| Income Statement | |
| Revenue (TTM) | 70.92M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -15.50 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -385.35M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 99.10% |
| Profit Margin (Quarterly) | -280.3% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | 0 |
| Price and Valuation | |
| Market Cap | 2.630B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 36.75 |
| PE Ratio (TTM) | -- |
| Price to Book Value | 15.50 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | 2.053 |
| Free Cash Flow (Quarterly) | -59.52M |
| Return on Equity (TTM) | -123.8% |
View All ICPT News
ICPT News
-
WireHeadlineTime (ET)
-
Yahoo08/15 17:54
-
Yahoo08/14 09:38
-
Yahoo08/14 08:05
-
Yahoo08/13 06:36
-
Globe Newswire08/10 17:00
-
Yahoo08/08 07:10
-
MT Newswires08/01 13:16
-
Yahoo08/01 10:46
-
Yahoo08/01 09:58
-
PR Newswire08/01 09:31
View All Events
ICPT Events
| Date | Type | Description |
|---|---|---|
| 06/27/2017 09:00 EDT | Misc | Intercept Pharmaceuticals Inc Annual General Meeting in 2016 |
| 05/04/2017 08:30 EDT | Misc | Intercept Pharmaceuticals Inc First Quarter Earnings Conference Call in 2017 |
| 05/04/2017 | Earnings | Intercept Pharmaceuticals Inc First Quarter Earnings in 2017 Release |
| 02/23/2017 08:30 EDT | Misc | Intercept Pharmaceuticals Inc Fourth Quarter Earnings Conference Call in 2016 |
| 02/23/2017 | Earnings | Intercept Pharmaceuticals Inc Fourth Quarter Earnings in 2016 Release |
| 11/03/2016 08:30 EDT | Misc | Intercept Pharmaceuticals Inc Third Quarter Earnings Conference Call in 2016 |
| 11/03/2016 | Earnings | Intercept Pharmaceuticals Inc Third Quarter Earnings in 2016 Release |
ICPT Fundamentals
Income Statement View Statement
ICPT Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
ICPT One Page Reports
- One Page Report Download
ICPT Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Target Price | |
| Price | 104.78 |
| Price Target | Upgrade |
Edit
Profile
- URL: http://www.interceptpharma.com
- Investor Relations URL: http://ir.interceptpharma.com/index.cfm
- HQ State/Province: New York
- Sector: Healthcare
- Industry: Biotechnology
- Next Earnings Release: N/A
- Last Earnings Release: May. 04, 2017
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Intercept Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the development and commercialization of novel therapeutics to treat non-viral, progressive liver diseases with high unmet medical need.
ICPT Comparables
EditICPT Excel Add-In Codes
- Name: =YCI("ICPT","name")
- Description: =YCI("ICPT","description")
- Sector: =YCI("ICPT","sector")
- Industry: =YCI("ICPT","industry")
- Est. Current Fiscal Year End: =YCI("ICPT","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other ICPT Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- ICPT Tweets Stocktwits
Advertisement
